VNQ vs XBI
Vanguard Real Estate ETF vs SPDR S&P Biotech ETF
- • VNQ has the lower expense ratio at 0.13% vs 0.35% for XBI.
- • VNQ pays a higher dividend yield (3.60%).
Side-by-side metrics
| Metric | VNQ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.13% | 0.35% |
Dividend yield Trailing 12-month yield. | 3.60% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $71.35B | $10.73B |
YTD return | 11.54% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 1.10 |
P/E ratio | 31.15 | — |
Last price | $97.46 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VNQ top holdings
| VRTPX | Vanguard Real Estate II Index | 14.49% |
| WELL | Welltower Inc | 7.65% |
| PLD | Prologis Inc | 7.14% |
| EQIX | Equinix Inc | 5.63% |
| AMT | American Tower Corp | 4.65% |
| SPG | Simon Property Group Inc | 3.56% |
| DLR | Digital Realty Trust Inc | 3.49% |
| O | Realty Income Corp | 3.03% |
| PSA | Public Storage | 2.56% |
| VTR | Ventas Inc | 2.14% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VNQ
VNQ (Vanguard Real Estate ETF) is US REITs and real-estate operating companies. Managed by Vanguard, the fund carries $71.3B in assets under management, an expense ratio of 0.13%, a dividend yield of 3.60%. Its largest holding is Vanguard Real Estate II Index (VRTPX), which represents 14.5% of the portfolio. Real Estate is the fund's largest sector exposure at 99.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.